Beam Therapeutics Inc. (BEAM)

NASDAQ: BEAM · Real-Time Price · USD

19.91

-0.02 (-0.10%)

At close: May 01, 2025, 3:59 PM

20.25

1.71%

Pre-market: May 02, 2025, 06:55 AM EDT

Beam Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Net Income	-376.74M	-132.53M	-289.09M	-370.64M	-194.59M	-78.33M	-116.74M	-8M
Depreciation & Amortization	21.93M	20.01M	14.15M	7.45M	4.74M	3.5M	650K	11K
Stock-Based Compensation	n/a	98.65M	84.32M	43.57M	15.38M	7.03M	7M	198K
Other Working Capital	-112.03M	-108.88M	249.25M	110.44M	5.29M	-14.8M	7.64M	14K
Other Non-Cash Items	7.57M	-18.87M	-38.48M	158.86M	9.87M	2.02M	66.96M	3.85M
Deferred Income Tax	n/a	n/a	n/a	-16.77M	63.52M	4.48M	11.75M	500K
Change in Working Capital	n/a	-116.45M	251.63M	111.25M	5.35M	-10.71M	10.07M	740K
Operating Cash Flow	-347.25M	-149.19M	22.53M	-66.27M	-95.74M	-72M	-20.3M	-2.71M
Capital Expenditures	-8.95M	-33.73M	-48.95M	-46.81M	-16.36M	-12.52M	-13.12M	-346K
Cash Acquisitions	n/a	n/a	412.38M	620K	83.77M	54.14M	n/a	n/a
Purchase of Investments	-486.44M	-984.34M	-1.62B	-777.22M	-282.36M	-130.21M	-300K	n/a
Sales Maturities Of Investments	680.39M	1.09B	1.2B	529.27M	198.6M	76.07M	n/a	n/a
Other Investing Acitivies	n/a	n/a	-412.38M	-247.95M	-83.77M	-54.14M	-300K	n/a
Investing Cash Flow	185.01M	71.84M	-461.34M	-294.14M	-100.12M	-66.66M	-13.42M	-346K
Debt Repayment	-485K	-2.25M	-2.29M	-2.12M	1.7M	5.71M	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	-25.19M	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	-12.71M	n/a	n/a
Other Financial Acitivies	8.22M	8.53M	5.62M	810K	1.1M	10.38M	10K	n/a
Financial Cash Flow	7.74M	276.45M	111.59M	756.14M	322.32M	41.28M	179.73M	4.98M
Net Cash Flow	-154.5M	199.09M	-327.22M	395.73M	126.46M	-97.38M	146M	1.93M
Free Cash Flow	-356.19M	-182.93M	-26.42M	-113.08M	-112.1M	-84.52M	-33.42M	-3.05M